EMAIL DETAILS

I connected w them re FDA issue this am and will do some follow up work on that.


Sent with Good (www.good.com)


-----Original Message-----
From: Christopher Boies
Sent: Friday, March 18, 2016 05:13 PM Eastern Standard Time
To: 'hbiden@rosemontseneca.com'; Lisa Barclay
Subject: RE: NW Bio

I'm traveling next week, but can meet the following week if that works. Thanks


Sent with Good (www.good.com)


-----Original Message-----
From: hbiden@rosemontseneca.com [hbiden@rosemontseneca.com<mailto:hbiden@rosemontseneca.com>]
Sent: Friday, March 18, 2016 01:36 PM Eastern Standard Time
To: Lisa Barclay
Cc: Christopher Boies
Subject: Re: NW Bio

Thanks Lisa. Also, I'm re-looping Chris in. They want to head up to NY offices and engage regarding stock manipulation.

Chris- I think you spoke to them a few months ago. Could you let me know when you possibly meet them next week. Thanks

RHB
202-333-1880

On Mar 18, 2016, at 9:49 AM, Lisa Barclay <LBarclay@BSFLLP.com<mailto:LBarclay@BSFLLP.com>> wrote:

Just FYI, I did a small amount of work for them in December, and they have not paid us for it yet. It’s only a few thousand dollars, and I am going to have accounting re-send the bill, but just wanted to flag. I am not going to press them on it at this point.

Lisa

From: Hunter Biden [mailto:hbiden@rosemontseneca.com]
Sent: Thursday, March 17, 2016 4:30 PM
To: Lisa Barclay
Cc: Joan Peugh
Subject: NW Bio

Lisa-
Hope you are well. Do you have some time tomorrow to talk with the folks from Northwest Biotherapeutics? The matter is pressing, so we will make time for whatever works on your end. I'm copying my assistant Joan who can help coordinate. Thanks for your assistance.

Best,
Hunter

--
R. Hunter Biden
Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880

________________________________
The information contained in this electronic message is confidential information intended only for the use of the named recipient(s) and may contain information that, among other protections, is the subject of attorney-client privilege, attorney work product or exempt from disclosure under applicable law. If the reader of this electronic message is not the named recipient, or the employee or agent responsible to deliver it to the named recipient, you are hereby notified that any dissemination, distribution, copying or other use of this communication is strictly prohibited and no privilege is waived. If you have received this communication in error, please immediately notify the sender by replying to this electronic message and then deleting this electronic message from your computer. [v.1]

________________________________
The information contained in this electronic message is confidential information intended only for the use of the named recipient(s) and may contain information that, among other protections, is the subject of attorney-client privilege, attorney work product or exempt from disclosure under applicable law. If the reader of this electronic message is not the named recipient, or the employee or agent responsible to deliver it to the named recipient, you are hereby notified that any dissemination, distribution, copying or other use of this communication is strictly prohibited and no privilege is waived. If you have received this communication in error, please immediately notify the sender by replying to this electronic message and then deleting this electronic message from your computer. [v.1]